title: Responsiveness to change and interpretability of the simplified psoriasis index.
abstract: The Simplified Psoriasis Index (SPI) is a summary measure of psoriasis with separate components for current severity (weighted for functionally or psychosocially important sites), psychosocial impact, and past behavior. The current severity components of the professionally assessed SPI (proSPI-s) and self-assessed SPI (saSPI-s) have each been shown to be valid and reliable. Their responsiveness to change and equivalence to the current standard (Psoriasis Area and Severity Index, PASI) were investigated. Responsiveness and minimum clinically important differences (MCIDs) were derived from PASI changes from baseline at weeks 4 (n=100) and 10 (n=65) in patients commencing therapy for psoriasis. Receiver operating characteristic (ROC) analysis confirmed that both measures detected responsiveness well (area under the curve (AUC)=0.72-0.96). On ROC and PASI-based anchor analysis, MCIDs equated to mean absolute and percentage changes of 5 and 60% (proSPI-s), and 7 and 70% (saSPI-s). Satisfactory response as defined by 75% reduction in PASI equated to 85 and 95% reductions in proSPI-s and saSPI-s, respectively. PASI-equivalent cutoff scores for mild (PASI<10) and severe (PASI>20) psoriasis were <9 and >18 for proSPI-s (n=300) and <10 and >20 for saSPI-s (n=200; AUC=0.86-0.96). These studies further support the validity of SPI for use in routine clinical practice.
authors.affiliation: Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
authors.forename: Leena
authors.initials: L
authors.lastname: Chularojanamontri
authors.affiliation: Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
authors.forename: Christopher E M
authors.initials: CEM
authors.lastname: Griffiths
authors.affiliation: Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: r.chalmers@man.ac.uk.
authors.forename: Robert J G
authors.initials: RJG
authors.lastname: Chalmers
mesh_terms: D000328:Adult; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy / Q000473:pathology* / Q000523:psychology*; D011788:Quality of Life; D012372:ROC Curve; D015203:Reproducibility of Results; D012720:Severity of Illness Index; D012867:Skin / Q000473:pathology*
references.citation: J Clin Epidemiol. 2008 Feb;61(2):102-9
references.pmid: 18177782
references.citation: J Clin Epidemiol. 2010 Jan;63(1):28-36
references.pmid: 19800198
references.citation: J Invest Dermatol. 2013 Aug;133(8):1956-62
references.pmid: 23807685
references.citation: Arch Dermatol. 2011 Jan;147(1):95-8
references.pmid: 20855674
references.citation: Lancet. 2005 Oct 15-21;366(9494):1367-74
references.pmid: 16226614
references.citation: Health Technol Assess. 2009 Jun;13 Suppl 1:55-60
references.pmid: 19567215
references.citation: J Am Acad Dermatol. 2005 Sep;53(3):547-51
references.pmid: 16112384
references.citation: J Clin Epidemiol. 2009 Apr;62(4):374-9
references.pmid: 19013766
references.citation: J Clin Epidemiol. 2011 May;64(5):487-96
references.pmid: 21109396
references.citation: Clin Dermatol. 2010 Jan-Feb;28(1):67-72
references.pmid: 20082954
references.citation: J Eval Clin Pract. 2000 Feb;6(1):39-49
references.pmid: 10807023
references.citation: J Invest Dermatol. 2010 Apr;130(4):933-43
references.pmid: 20043014
references.citation: BMC Med Res Methodol. 2010 Mar 18;10:22
references.pmid: 20298572
references.citation: J Am Acad Dermatol. 2004 Jun;50(6):859-66
references.pmid: 15153885
references.citation: Eur J Dermatol. 2006 Mar-Apr;16(2):167-71
references.pmid: 16581570
references.citation: Br J Dermatol. 2000 Apr;142(4):728-32
references.pmid: 10792223
references.citation: J Invest Dermatol. 2010 May;130(5):1318-22
references.pmid: 20032989
references.citation: Med Decis Making. 1988 Jul-Sep;8(3):197-203
references.pmid: 3398748